A detailed history of Bank Of America Corp transactions in Repligen Corp stock. As of the latest transaction made, Bank Of America Corp holds 404,897 shares of RGEN stock, worth $59.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
404,897
Previous 422,785 4.23%
Holding current value
$59.1 Million
Previous $77.8 Million 34.36%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$120.0 - $182.95 $2.15 Million - $3.27 Million
-17,888 Reduced 4.23%
404,897 $51 Million
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $1.17 Million - $1.43 Million
6,864 Added 1.65%
422,785 $77.8 Million
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $2.84 Million - $4.61 Million
24,867 Added 6.36%
415,921 $74.8 Million
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $6.52 Million - $8.49 Million
-47,073 Reduced 10.74%
391,054 $55.3 Million
Q1 2023

May 12, 2023

SELL
$154.26 - $198.1 $564,591 - $725,046
-3,660 Reduced 0.83%
438,127 $73.8 Million
Q4 2022

Feb 10, 2023

SELL
$162.42 - $220.56 $13.1 Million - $17.8 Million
-80,730 Reduced 15.45%
441,787 $74.8 Million
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $5.39 Million - $8.61 Million
33,606 Added 6.87%
522,517 $97.8 Million
Q2 2022

Aug 12, 2022

SELL
$140.68 - $188.02 $8.11 Million - $10.8 Million
-57,675 Reduced 10.55%
488,911 $79.4 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $10.7 Million - $17.1 Million
-66,333 Reduced 10.82%
546,586 $103 Million
Q4 2021

Feb 08, 2022

BUY
$247.59 - $304.47 $5.48 Million - $6.74 Million
22,152 Added 3.75%
612,919 $162 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $3.82 Million - $6.36 Million
-19,629 Reduced 3.22%
590,767 $171 Million
Q2 2021

Sep 13, 2021

BUY
$165.87 - $220.95 $101 Million - $135 Million
610,396 New
610,396 $122 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.1B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.